Are you in compliance?

Don't miss out! Sign up today for our weekly newsletters and stay abreast of important GRC-related information and news.


Status message

Start your free, no obligation 5-day trial to continue exploring with full access.

Senate bill would restrict pharmaceutical advertising

Joe Mont | January 11, 2019

Senate Democrats are advocating for the End Taxpayer Subsidies for Drug Ads Act, legislation that would prohibit pharmaceutical drug manufacturers from claiming tax deductions for consumer advertising expenses.

The bill, announced Friday, was initially co-authored by Sens. Elizabeth Warren (D-Mass.) and Jeanne Shaheen (D-N.H.). Advertising expenses by pharmaceutical drug manufacturers have more than quadrupled over the past two decades, they say, rising from $1.3 billion in 1997 to $6 billion in 2016. During that same time period, advertising from drug companies increased from 79,000 ads to 4.6 million, including 663,000 TV commercials. “Economists have estimated that nearly one third of the growth in drug companies’ spending can be attributed to the increase in advertising for prescription drugs,” a statement by the two senators says. 

Under current law, drug manufacturers are allowed to deduct the cost of advertising expenses from federal taxes. “This aggressive...

Read this single article for $49, or click the subscribe button below to review subscription options.

Enjoy unlimited access to thousands of articles, browse five years of digital magazines, qualify for reduced admission to events, and more.